WEE1 Inhibitor MK-1775, Docetaxel, and Cisplatin Before Surgery in Treating Patients With Borderline Resectable Stage III-IVB Squamous Cell Carcinoma of the Head and Neck
PHASE1
This phase I trial studies the side effects and the best dose of WEE1 inhib...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Influence of Prior Chemotherapy on Clinical Benefit With Erlotinib in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer With or Without EGFR Gene Mutation
PHASE2
To compare the differential influence of 1st line doublet chemotherapy cont...
Study of Chemotherapy With Cisplatin/Carboplatin, and Docetaxel With or Without Erlotinib in Patients With Head and Neck Squamous Cell Carcinomas Amenable for Surgical Resection
PHASE2
The goal of this clinical research study is to learn if adding erlotinib to...